Technical Analysis for PRVB - Provention Bio, Inc.

Grade Last Price % Change Price Change
F 15.0 -3.23% -0.50
PRVB closed down 3.23 percent on Friday, January 15, 2021, on 3.44 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical PRVB trend table...

Date Alert Name Type % Chg
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
BB Squeeze Ended Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -3.23%
Older End-of-Day Signals for PRVB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Provention Bio, Inc. Description

Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohn’s disease, ulcerative colitis, lupus and other viral diseases. The Company’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product candidate in its Phase III clinical trial that is developed for the interception of T1D. PRV-6527 is an oral CSF-1R inhibitor for the treatment of Crohn’s disease. PRV-300 is developed for the treatment of ulcerative colitis. PRV-3279 is developed to treat lupus disease. PRV-101 is a multivalent coxsackie virus (CVB) vaccine for the prevention of acute CVB and the prevention of the onset of T1D.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Disease Diabetes Autoimmune Diseases Ulcer Colitis Ulcerative Colitis Diarrhea Lupus Abdominal Pain Crohn's Disease Viral Disease Viral Diseases Immune Mediated Diseases

Is PRVB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.05
52 Week Low 4.72
Average Volume 729,807
200-Day Moving Average 13.64
50-Day Moving Average 16.26
20-Day Moving Average 17.45
10-Day Moving Average 17.31
Average True Range 1.29
ADX 21.28
+DI 18.32
-DI 23.92
Chandelier Exit (Long, 3 ATRs ) 16.19
Chandelier Exit (Short, 3 ATRs ) 18.53
Upper Bollinger Band 19.32
Lower Bollinger Band 15.58
Percent B (%b) -0.15
BandWidth 21.45
MACD Line 0.00
MACD Signal Line 0.37
MACD Histogram -0.365
Fundamentals Value
Market Cap 847.32 Million
Num Shares 56.5 Million
EPS -0.94
Price-to-Earnings (P/E) Ratio -15.91
Price-to-Sales 0.00
Price-to-Book 6.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.82
Resistance 3 (R3) 16.92 16.40 16.52
Resistance 2 (R2) 16.40 15.94 16.36 16.42
Resistance 1 (R1) 15.70 15.65 15.45 15.61 16.32
Pivot Point 15.19 15.19 15.06 15.14 15.19
Support 1 (S1) 14.49 14.72 14.23 14.39 13.68
Support 2 (S2) 13.97 14.44 13.92 13.58
Support 3 (S3) 13.27 13.97 13.48
Support 4 (S4) 13.18